Correction to: Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
Acta Neuropathol Commun. 2020 Aug 3;8(1):121.
doi: 10.1186/s40478-020-01005-5.
1 Department of Imaging and Pathology, KU-Leuven, Leuven, Belgium. [email protected].
2 Department of Pathology, UZ-Leuven, Leuven, Belgium. [email protected].
3 Leuven Brain Institute, KU-Leuven, Leuven, Belgium. [email protected].
4 Laboratory for Neuropathology - Institute of Pathology, University of Ulm, Ulm, Germany. [email protected].
5 Department of Imaging and Pathology, KU-Leuven, Leuven, Belgium.
6 Leuven Brain Institute, KU-Leuven, Leuven, Belgium.
7 Department of Pathology, UZ-Leuven, Leuven, Belgium.
8 Laboratory for Neuropathology - Institute of Pathology, University of Ulm, Ulm, Germany.
9 Department of Gene Therapy, University of Ulm, Ulm, Germany.
10 Department of Neurosciences, KU-Leuven, Herestraat 49, 3000, Leuven, Belgium.
11 Department of Neurology, UZ-Leuven, Leuven, Belgium.
12 Department of Geriatric Psychiatry, UZ-Leuven, Leuven, Belgium.
13 Department of Neurology, University of Ulm, Ulm, Germany.
14 Department of Geriatrics, University Medical Center Göttingen, Göttingen, Germany.
15 Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ, USA.
16 Hermes Medical Solutions AB, Stockholm, Sweden.
17 Department of Psychiatry and Neurochemistry, Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenborg, Sweden.
18 Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, St. James Hospital, Leeds, UK.
19 GE Healthcare Life Sciences, Amersham, UK.
20 Department of Neurology, University of Bonn, Bonn, Germany.